Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-19,591
Closed -$6.13M 107
2016
Q3
$6.13M Sell
19,591
-520
-3% -$154K 0.33% 56
2016
Q2
$4.86M Sell
20,111
-2,943
-13% -$776K 0.26% 78
2016
Q1
$6M Buy
23,054
+1,501
+7% +$396K 0.32% 65
2015
Q4
$6.6M Buy
21,553
+11,212
+108% +$3.22M 0.39% 50
2015
Q3
$3.02M Sell
10,341
-7,113
-41% -$2.35M 0.19% 115
2015
Q2
$7.05M Sell
17,454
-4,439
-20% -$1.78M 0.38% 55
2015
Q1
$9.24M Sell
21,893
-381
-2% -$150K 0.49% 45
2014
Q4
$7.56M Sell
22,274
-2,887
-11% -$934K 0.41% 49
2014
Q3
$8.32M Sell
25,161
-952
-4% -$314K 0.47% 41
2014
Q2
$8.23M Sell
26,113
-67
-0.3% -$20.2K 0.45% 44
2014
Q1
$8.01M Sell
26,180
-4,810
-16% -$1.53M 0.46% 45
2013
Q4
$8.66M Sell
30,990
-462
-1% -$119K 0.44% 43
2013
Q3
$7.57M Sell
31,452
-608
-2% -$136K 0.43% 42
2013
Q2
$6.9M Buy
+32,060
New +$6.85M 0.42% 44

Other funds holding BIIB

Deere & Company's BIIB Position: Q4 2016 in Review

Deere & Company sold out of Biogen (BIIB) in Q4 2016, closing a stake of 19,591 shares — an estimated $6.13M sold.

Deere & Company first reported a position in BIIB in Q2 2013 and held it in 14 quarters. The position peaked at $9.24M in Q1 2015. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • Deere & Company reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
  • Deere & Company sold 19,591 Biogen shares in Q4 2016, an estimated $6.13M.
  • Deere & Company first reported a position in Biogen in Q2 2013 and held it in 14 quarters.
  • Deere & Company's Biogen position peaked at $9.24M in Q1 2015.
  • 1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on Deere & Company's 13F filing for Q4 2016, filed 13 Feb 2017.